To help Merck improve patient adherence across its brands, we created this Adherence Navigator for doctors. It educates about the prevalence and impact of non-adherence, and help them address their patients’ primary adherence concerns – Commitment, Concern, and Cost – with effective tools like the Merck Adherence Estimator and Teach-Back Technique.

MS patients are typically given too much information to digest upon diagnosis. This Decision Kit from Novartis prioritizes, organizes, and filters both disease-state information and EXTAVIA product information to make their decision process easier. It also incorporates certain focus-group findings we learned were helpful for people with MS, like large font, heavy-stock paper, and an audio version of the kit on DVD. (Please note, this work got to mechanical stage but was not produced.)

Allergic asthma is asthma that’s triggered by allergens such as pet dander and dust. This treatment guide incorporates the latest (and current) XOLAIR DTC campaign we developed for Novartis as well as a new pediatric indication. XOLAIR was first approved in 2003 to treat moderate-to-severe allergic asthma in adults and adolescents age 12+. In July 2016, the indication was expanded to include children 6-11 years old.

What young woman doesn't reach for a fashion magazine? That's the idea behind these quarterly in-office mini-magazines for Gardasil. Their fashion look-and-feel was designed to cut through waiting-room clutter and capture the attention of young women about to see their doctor – putting the risks of HPV top-of-mind right before they're called into their appointment. True stories from real cervical cancer survivors were featured to add urgency to consideration and to offset any anxiety with hope.